Visualizing the target estimand in comparative effectiveness studies with multiple treatments
Journal of Comparative Effectiveness Research · 2024
DOI: 10.57264/cer-2023-0089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Gabrielle Simoneau und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biogen Canada, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Crotonates, Hydroxybutyrates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Comparative effectiveness research using real-world data often involves pairwise propensity score matching to adjust for confounding bias. We show that corresponding treatment effect estimates may have limited external validity, and propose two visualization tools to clarify the target estimand. Materials & methods: We conduct a simulation study to demonstrate, with bivariate ellipses and joy plots, that differences in covariate distributions across treatment groups may affect the external validity of treatment effect estimates. We showcase how these visualization tools can facilitate the interpretation of target estimands in a case study comparing the effectiveness of teriflunomide (TERI), dimethyl fumarate (DMF) and natalizumab (NAT) on manual dexterity in patients with multiple sclerosis.
Results
In the simulation study, estimates of the treatment effect greatly differed depending on the target population. For example, when comparing treatment B with C, the estimated treatment effect (and respective standard error) varied from -0.27 (0.03) to -0.37 (0.04) in the type of patients initially receiving treatment B and C, respectively. Visualization of the matched samples revealed that covariate distributions vary for each comparison and cannot be used to target one common treatment effect for the three treatment comparisons. In the case study, the bivariate distribution of age and disease duration varied across the population of patients receiving TERI, DMF or NAT. Although results suggest that DMF and NAT improve manual dexterity at 1 year compared with TERI, the effectiveness of DMF versus NAT differs depending on which target estimand is used.
Conclusion
Visualization tools may help to clarify the target population in comparative effectiveness studies and resolve ambiguity about the interpretation of estimated treatment effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biogen Canada, Toronto, ON, Canada.
- Biogen International GmbH, Baar, Zug, 6340, Switzerland.
- Julius Centre for Health Sciences & Primary Care, University Medical Centre, University of Utrecht, Utrecht, 3584CG, The Netherlands.
- Smart Data Analysis & Statistics, Utrecht, 3524HM, The Netherlands.
- Medip Analytics, Nijmegen, 6534AT, The Netherlands.
- Johnson & Johnson, New Brunswick, NJ, USA.
ORCID-Profile: Gabrielle Simoneau, Marian Mitroiu, Thomas Pa Debray, Stan Rw Wijn, Changyu Shen, Fabio Pellegrini, Carl de Moor
Zitieren
APA
Simoneau, G., Mitroiu, M., Debray, T. P., Wei, W., Wijn, S. R., Magalhães, J. C., Bohn, J., Shen, C., Pellegrini, F., & Moor, C. (2024). Visualizing the target estimand in comparative effectiveness studies with multiple treatments. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2023-0089
Vancouver
Simoneau G, Mitroiu M, Debray TP, Wei W, Wijn SR, Magalhães JC, et al. Visualizing the target estimand in comparative effectiveness studies with multiple treatments. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2023-0089
BibTeX
@article{Simoneau2024,
author = {Simoneau, Gabrielle and Mitroiu, Marian and Debray, Thomas Pa and Wei, Wei and Wijn, Stan Rw and Magalhães, Joana Caldas and Bohn, Justin and Shen, Changyu and Pellegrini, Fabio and Moor, Carl de},
title = {Visualizing the target estimand in comparative effectiveness studies with multiple treatments},
journal = {Journal of Comparative Effectiveness Research},
year = {2024},
doi = {10.57264/cer-2023-0089}
}
EUVIMED